Submissions from 2024
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR), Manmeet Ahluwalia, Ahmad Ozair, and Atulya Khosla
AAPM WGTG51 Report 385: Addendum to the AAPM's TG-51 protocol for clinical reference dosimetry of high-energy electron beams, Stephan Davis
Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez, Eduardo Pons, and Andrew Wroe
Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
A prospective, multicenter trial of low-intensity focused ultrasound (LIFU) for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE), Manmeet Ahluwalia, Ahmad Ozair, Justin Sporrer, and Michael McDermott
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections, Lourdes MenendezAlvarado, Alice Landayan, Kelsey Williams, Corey Frederick, Zhenwei Zhang, and Timothy Gauthier
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval Leon
The joy of surgery: how surgeons experience joy, time, and support, Horacio Asbun
Preparing for Day Zero: Examining the Effects and Lived Experiences of Participating in the Ceremony of Hope as a Religious Coping Intervention among Hematopoietic Stem Cell Transplant Patients, David Stackhouse, Shelli Chernesky, Sammy Alvero, Karla Ruiz Tamayo, Denise Dujon, Nina Aguda, Mirian Soler, Natalie Bermudez, Ruben Ramos, Felipe Zuluaga, and Liuvys Zaldivar
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta
Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study, Mohammad Ganiyani, Diya Jayram, and Manmeet Ahluwalia
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press
Prevention of Brain Metastases: A New Frontier, Shreyas Bellur and Manmeet Ahluwalia
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review, Manmeet Ahluwalia
Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis., Mohammad Ganiyani, Ahmad Ozair, Diya Jayram, and Manmeet Ahluwalia
Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan, Mainak Bardhan, Charlie Hurmiz, Mohammad Ganiyani, Reshma Mahtani, and Manmeet Ahluwalia
Phase 2 trial of pembrolizumab plus SurVaxM for patients with glioblastoma at first recurrence (RESURGe), Manmeet Ahluwalia and Ahmad Ozair
Survival outcomes of small cell variant bladder cancer: Analysis from a nationwide study, Mohammad Ganiyani, Saba Ahmad, Muni Rubens, Mukesh Roy, Bruno Bastos, Manuel Ozambela Jr, and Murugesan Manoharan
A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR), Manmeet Ahluwalia, Ahmad Ozair, Mainak Bardhan, Dilanis Perche, Muni Rubens, Yazmin Odia, Rupesh Kotecha, Daniel Leon Ariza, Michael McDermott, Ana Cristina Sandoval Leon, Reshma Mahtani, Shreyas Bellur, and David Peereboom
A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE), Manmeet Ahluwalia, Yazmin Odia, and Ahmad Ozair